United-Guardian, Inc. (UG) |
| 7.33 -0.87 (-10.61%) 07-28 16:00 |
| Open: | 7.47 |
| High: | 8.03 |
| Low: | 7.25 |
| Volume: | 28,388 |
| Market Cap: | 34(M) |
| PE Ratio: | 14.1 |
| Exchange: | NASDAQ Global Market |
| Industry: | Household & Personal Products |
| Sector: | Consumer Defensive |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 8.45 |
| Resistance 1: | 7.87 |
| Pivot price: | 7.52 |
| Support 1: | 6.94 |
| Support 2: | 5.77 |
| 52w High: | 8.78 |
| 52w Low: | 5.58 |
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
| EPS | 0.520 |
| Book Value | 2.370 |
| PEG Ratio | 1.12 |
| Gross Profit | 1.135 |
| Profit Margin (%) | 21.61 |
| Operating Margin (%) | 22.37 |
| Return on Assets (ttm) | 11.2 |
| Return on Equity (ttm) | 21.8 |
Tue, 28 Jul 2026
United-Guardian Inc (UG) Institutional Confidence - TradingKey
Mon, 27 Jul 2026
United-Guardian Inc (UG) Cash Flow - TradingKey
Mon, 27 Jul 2026
UG|United-Guardian Inc|Price:8.200|Chg%:+0.580 - TradingKey
Sun, 26 Jul 2026
United-Guardian, Inc. Revenue Breakdown – NASDAQ:UG - TradingView
Fri, 24 Jul 2026
UG|United-Guardian Inc|Price:7.620|Chg%:-0.110 - TradingKey
Fri, 24 Jul 2026
UG|United-Guardian Inc|Price:7.620|Chg%:-0.110 - TradingKey
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |